Table 1. Clinicopathological data of the 309 non-metastatic clear cell renal cell carcinoma patients included in the study.
| Characteristic | Value |
|---|---|
| Age (y) | 55.0±12.0 |
| Male | 212 (68.6) |
| Symptomatic | 40 (12.9) |
| Body mass index (kg/m2) | 24.2±3.2 |
| Tumor size (cm) | 4.7±2.5 |
| Tumor stage | |
| T1 | 211 (68.3) |
| T2 | 23 (7.4) |
| T3 | 72 (23.3) |
| T4 | 3 (1.0) |
| Grade | |
| 1 | 20 (6.5) |
| 2 | 91 (29.4) |
| 3 | 164 (53.1) |
| 4 | 31 (10.0) |
| pNLR | 2.5±1.8 |
| pPLR | 140.0±61.0 |
| rNLR | 1.9±1.6 |
| rPLR | 109.0±45.0 |
| Follow-up time (mo) | 93 |
Values are presented as mean±standard deviation, number (%), or number only.
pNLR, preoperative neutrophil-to-lymphocyte ratio; pPLR, preoperative platelet-to-lymphocyte ratio; rNLR, NLR at recurrence or quasirecurrence; rPLR, PLR at recurrence or quasi-recurrence.